BONFANTI, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 2.116
NA - Nord America 1.753
AS - Asia 1.492
SA - Sud America 159
AF - Africa 98
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.634
Nazione #
US - Stati Uniti d'America 1.660
IT - Italia 513
SG - Singapore 485
CN - Cina 473
GB - Regno Unito 462
DE - Germania 440
HK - Hong Kong 154
SE - Svezia 127
BR - Brasile 126
RU - Federazione Russa 125
IN - India 93
NL - Olanda 92
CA - Canada 77
FI - Finlandia 67
IE - Irlanda 66
FR - Francia 64
TR - Turchia 61
CI - Costa d'Avorio 38
ID - Indonesia 36
VN - Vietnam 35
JP - Giappone 33
DK - Danimarca 25
TW - Taiwan 25
KR - Corea 22
ES - Italia 19
AT - Austria 18
CH - Svizzera 17
UA - Ucraina 15
AU - Australia 14
IQ - Iraq 13
NO - Norvegia 13
ZA - Sudafrica 13
MX - Messico 12
PL - Polonia 11
GR - Grecia 10
AR - Argentina 9
BE - Belgio 9
PK - Pakistan 9
GH - Ghana 8
UZ - Uzbekistan 8
IL - Israele 7
IR - Iran 7
MA - Marocco 7
CL - Cile 6
BD - Bangladesh 5
CO - Colombia 5
RO - Romania 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
SL - Sierra Leone 4
TH - Thailandia 4
TZ - Tanzania 4
EC - Ecuador 3
ET - Etiopia 3
LT - Lituania 3
PT - Portogallo 3
PY - Paraguay 3
SC - Seychelles 3
VE - Venezuela 3
BG - Bulgaria 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
JO - Giordania 2
KH - Cambogia 2
MW - Malawi 2
NG - Nigeria 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
EU - Europa 1
GI - Gibilterra 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
SN - Senegal 1
SO - Somalia 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 5.634
Città #
Southend 397
Ashburn 268
Singapore 265
Dallas 237
Frankfurt am Main 225
Milan 179
Chandler 162
Hong Kong 135
Beijing 88
Dublin 65
Fairfield 55
Hefei 49
Los Angeles 48
Helsinki 42
Hanover 41
Princeton 40
Abidjan 38
Seattle 38
Istanbul 36
Wilmington 36
Bengaluru 34
Toronto 34
Munich 33
Council Bluffs 32
New York 31
Santa Clara 31
Cambridge 30
Shanghai 27
Ann Arbor 26
Dearborn 26
Jakarta 25
Boardman 24
Berlin 23
Houston 23
Moscow 23
Phoenix 22
Woodbridge 22
Buffalo 20
Tokyo 18
Columbus 16
Des Moines 16
Rome 16
Ottawa 15
São Paulo 15
Zhongli District 15
Ankara 14
Nuremberg 14
San Jose 14
Amsterdam 13
Chicago 13
Fuzhou 13
Guangzhou 12
Ho Chi Minh City 12
Cangzhou 11
Chengdu 11
Nanjing 11
Piscataway 11
Turku 11
Vienna 11
Mumbai 10
The Dalles 10
Denver 9
London 9
Redwood City 9
Seoul 9
Capriate San Gervasio 8
Düsseldorf 8
Florence 8
Madrid 8
Warsaw 8
Wuhan 8
Zurich 8
Brooklyn 7
Central District 7
Chennai 7
Falls Church 7
Kent 7
Lappeenranta 7
Palermo 7
Paris 7
Shenzhen 7
Turin 7
Accra 6
Atlanta 6
Bexley 6
Boston 6
Brussels 6
Cape Town 6
Changsha 6
Jacksonville 6
Messina 6
Mexico City 6
Montreal 6
Orem 6
Roubaix 6
Sarpsborg 6
Vancouver 6
Bodio Lomnago 5
Camerano 5
Grafing 5
Totale 3.499
Nome #
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 546
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μl in Europe and North America: A pooled cohort observational study 417
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 332
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 271
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 263
High rates of 30-day mortality in patients with cirrhosis and COVID-19 261
Characteristics and clinical implications of carbapenemase-producing klebsiella pneumoniae colonization and infection, Italy 233
Timing of antiretroviral therapy initiation after a first AIDS-defining event : temporal changes in clinical attitudes in the ICONA cohort 225
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 205
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial 190
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 188
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting 173
Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or -treated individuals 168
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian association for the study of infectious and tropical disease 166
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 150
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous daa failure 148
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 147
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 144
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 144
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 136
Predictors of weight gain in patients treated with dolutegravir 128
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 122
Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort 121
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 118
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced dimalsease: a trial emulation 118
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort 106
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 104
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 91
Efficacy and Safety of Ceftazidime-Avibactam Alone versus Ceftazidime-Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort 84
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 78
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda 69
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir 58
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 32
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study 22
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 18
[Recommendations for the prevention of infective endocarditis in patients undergoing cardiovascular interventions] Linee di indirizzo per la prevenzione dell’endocardite infettiva nei pazienti sottoposti a interventi cardiovascolari 15
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple Regimen 11
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study 11
Totale 5.813
Categoria #
all - tutte 18.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.109


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021313 0 0 0 0 0 33 24 53 58 64 46 35
2021/2022615 43 44 56 46 41 29 52 52 76 62 39 75
2022/2023656 61 72 44 59 83 99 27 42 70 19 64 16
2023/2024660 20 50 38 54 115 79 62 54 17 40 74 57
2024/20251.184 55 85 39 110 92 67 83 112 79 127 107 228
2025/20261.674 254 237 394 282 256 251 0 0 0 0 0 0
Totale 5.813